CA2806726A1 - Prediction of and monitoring cancer therapy response based on gene expression profiling - Google Patents

Prediction of and monitoring cancer therapy response based on gene expression profiling Download PDF

Info

Publication number
CA2806726A1
CA2806726A1 CA2806726A CA2806726A CA2806726A1 CA 2806726 A1 CA2806726 A1 CA 2806726A1 CA 2806726 A CA2806726 A CA 2806726A CA 2806726 A CA2806726 A CA 2806726A CA 2806726 A1 CA2806726 A1 CA 2806726A1
Authority
CA
Canada
Prior art keywords
genes
cancer
therapy
subset
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2806726A
Other languages
English (en)
French (fr)
Inventor
Piyush Gupta
Tamer T. Onder
Eric S Lander
Robert Weinberg
Sendurai Mani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Broad Institute Inc
Whitehead Institute for Biomedical Research
Original Assignee
Broad Institute Inc
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Broad Institute Inc, Whitehead Institute for Biomedical Research filed Critical Broad Institute Inc
Publication of CA2806726A1 publication Critical patent/CA2806726A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2806726A 2010-08-02 2011-08-02 Prediction of and monitoring cancer therapy response based on gene expression profiling Pending CA2806726A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36992810P 2010-08-02 2010-08-02
US61/369,928 2010-08-02
PCT/US2011/046325 WO2012018857A2 (en) 2010-08-02 2011-08-02 Prediction of and monitoring cancer therapy response based on gene expression profiling

Publications (1)

Publication Number Publication Date
CA2806726A1 true CA2806726A1 (en) 2012-02-09

Family

ID=45560038

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2806726A Pending CA2806726A1 (en) 2010-08-02 2011-08-02 Prediction of and monitoring cancer therapy response based on gene expression profiling

Country Status (5)

Country Link
US (1) US20130260376A1 (enExample)
EP (1) EP2601315A4 (enExample)
JP (1) JP2013532489A (enExample)
CA (1) CA2806726A1 (enExample)
WO (1) WO2012018857A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI508727B (zh) * 2012-06-28 2015-11-21 Univ Nat Taiwan 一種胺碘酮用於製備抑制癌細胞轉移之醫藥組合物的用途

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101717177B1 (ko) * 2013-10-28 2017-03-16 주식회사 디앤피바이오텍 항암제 치료 반응성 및 생존 예후 예측용 마커
WO2015175305A1 (en) 2014-05-12 2015-11-19 Janssen Pharmaceutica Nv Biological markers for identifying patients for treatment with abiraterone acetate
JP6761798B2 (ja) * 2014-09-03 2020-09-30 ウェルマーカー バイオ カンパニー リミテッド タンパク質キナーゼ阻害剤に対する感受性予測用組成物、キット、及び方法
CN105886628B (zh) * 2016-04-29 2019-03-26 肖刻 Sprr1a基因在制备骨关节炎诊断产品中的应用
US20200071773A1 (en) * 2017-04-12 2020-03-05 Massachusetts Eye And Ear Infirmary Tumor signature for metastasis, compositions of matter methods of use thereof
CN112867495B (zh) * 2018-10-19 2024-08-20 韩国生命工学研究院 包含syt11抑制剂作为活性成分的胃癌治疗组合物
WO2020115261A1 (en) * 2018-12-07 2020-06-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating melanoma

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060031809A (ko) * 2003-06-09 2006-04-13 더 리젠츠 오브 더 유니버시티 오브 미시간 암 치료 및 진단용 조성물 및 방법
US7892740B2 (en) * 2006-01-19 2011-02-22 The University Of Chicago Prognosis and therapy predictive markers and methods of use
EP2036988A1 (en) * 2007-09-12 2009-03-18 Siemens Healthcare Diagnostics GmbH A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent
WO2009074968A2 (en) * 2007-12-12 2009-06-18 Ecole Polytechnique Federale De Lausanne (Epfl) Method for predicting the efficacy of cancer therapy
CA2723648A1 (en) * 2008-04-10 2009-10-15 Piyush Gupta Methods for identification and use of agents targeting cancer stem cells
RU2011101378A (ru) * 2008-06-16 2012-07-27 Сайвидон Дайагностикс Гмбх (De) Алгоритмы предсказания исхода у пациентов с узловой формой рака молочной железы после химиотерапии
WO2010076322A1 (en) * 2008-12-30 2010-07-08 Siemens Healthcare Diagnostics Inc. Prediction of response to taxane/anthracycline-containing chemotherapy in breast cancer
US20140030255A1 (en) * 2010-11-03 2014-01-30 Merck Sharp & Dohme Corp. Methods of predicting cancer cell response to therapeutic agents
EP2702173A1 (en) * 2011-04-25 2014-03-05 OSI Pharmaceuticals, LLC Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI508727B (zh) * 2012-06-28 2015-11-21 Univ Nat Taiwan 一種胺碘酮用於製備抑制癌細胞轉移之醫藥組合物的用途

Also Published As

Publication number Publication date
EP2601315A4 (en) 2014-01-29
EP2601315A2 (en) 2013-06-12
WO2012018857A2 (en) 2012-02-09
JP2013532489A (ja) 2013-08-19
US20130260376A1 (en) 2013-10-03
WO2012018857A3 (en) 2012-07-05
WO2012018857A8 (en) 2012-03-22

Similar Documents

Publication Publication Date Title
US7615349B2 (en) Melanoma gene signature
US20130260376A1 (en) Prediction of and Monitoring Cancer Therapy Response Based on Gene Expression Profiling
US10196691B2 (en) Colon cancer gene expression signatures and methods of use
EP2518166B1 (en) Thyroid fine needle aspiration molecular assay
US10428386B2 (en) Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same
Uchikado et al. Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma
US20070031873A1 (en) Predicting bone relapse of breast cancer
US20140030255A1 (en) Methods of predicting cancer cell response to therapeutic agents
Difilippantonio et al. Gene expression profiles in human non-small and small-cell lung cancers
Wiese et al. Identification of gene signatures for invasive colorectal tumor cells
EP1812590B1 (en) Methods and reagents for the detection of melanoma
EP1721159B1 (en) Breast cancer prognostics
US20110143946A1 (en) Method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent
CN101960022A (zh) Ⅱ期和ⅲ期结肠癌的分子分期和预后
EP2665835B1 (en) Prognostic signature for colorectal cancer recurrence
EP2333112B1 (en) Breast cancer prognostics
KR20180002882A (ko) 유전자 발현 프로파일 및 유방암에 대한 이의 용도
Nikolova et al. Genome-wide gene expression profiles of ovarian carcinoma: Identification of molecular targets for the treatment of ovarian carcinoma
US20080119367A1 (en) Prognosis of Renal Cell Carcinoma
KR20130023312A (ko) 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법
CA2904126C (en) Molecular markers in bladder cancer
EP3339450A2 (en) Molecular markers in bladder cancer

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160729